Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
type: MedicalStudy
description: A Randomized, Double Blind, Placebo Controlled, Parallel Group Design Study to Explore the Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2010-04
end date: 2012-04
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00572585
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Ulcerative Colitis
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Ulcerative Colitis

AI Analytics
type: Organization